What podcasts say about Moderna personalized mRNA cancer vaccines
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Moderna personalized mRNA cancer vaccines
16 statements · 12 positive · 1 negative · 3 neutral
Moderna’s melanoma vaccine success does not broadly validate its platform for other cancers.
“the melanoma win for the vaccine does not broadly validate the platform for other types of tumors or cancers.”
Open the episode · Micron Jumps; Northrop Grumman, Moderna SlideListen at 5:04
Moderna's cancer vaccine could address other markets with higher total addressable markets
“that it could actually hit other areas that maybe could have a higher TAM”
Open the episode · Weekly Roundup: Meta's AI-Driven Rally, Gen Digital Drops, Moderna SurgesListen at 3:24
Moderna’s personalized cancer vaccine could address other markets with higher TAM.
“that it could actually hit other areas that maybe could have a higher TAM”
Open the episode · Weekly Roundup: Meta's AI-Driven Rally, Gen Digital Drops, Moderna SurgesListen at 3:24
Prior melanoma trials reduced recurrence by approximately 50% and extended life
“it was reducing that recurrence by like 50%, extending life”
Open the episode · Knowing when to sell: How growth investor Michael Frazis manages riskListen at 40:51
Moderna is applying mRNA technology to skin-cancer treatment.
“you have had that mRNA technology that came out during COVID now finally being put to use for other things, most notably skin cancer in the case of Moderna.”
Open the episode · MediaTek Rises, Innovent Jumps, Woodside FallsListen at 1:55
Moderna’s mRNA platform is likely applicable to essentially every cancer type.
“this Moderna platform can basically be used for any form of cancer and that it's highly likely to Work.”
Open the episode · OpenAI Pauses Frontier Training, Elon's 100X Prediction Lands, Robot Beats Usain Bolt with Emad Mostaque | EP#282Listen at 2:02:47
Moderna-Merck personalized vaccine reduces melanoma recurrence.
“a personalized vaccine co developed by Moderna and Merck to reduce the recurrence of melanoma”
Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical UpListen at 4:03
The personalized vaccine can be customized to patients’ tumor mutations.
“they can customize the vaccines based on the patient's specific tumor mutations”
Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical UpListen at 4:16
The vaccine can be customized to patients’ specific tumor mutations.
“they can customize the vaccines based on the patient's specific tumor mutations”
Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical UpListen at 4:39
The personalized vaccine requires approval, with a timeline extending to 2027 or later.
“it has to... be approved for now we are looking at the timeline at 2027 plus”
Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical UpListen at 4:45
The personalized cancer vaccine still requires regulatory approval.
“it has to be approved”
Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical UpListen at 5:08
The personalized cancer vaccine timeline extends to 2027 or later.
“we are looking at the timeline at 2027 plus”
Open the episode · SK Hynix Up, Kuaishou Plunges, Sino Biopharmaceutical UpListen at 5:10
Moderna’s personalized cancer vaccine with Keytruda reduced melanoma recurrence in a late-stage trial.
“a personalized cancer vaccine combined with partner Merck's Keytruda helped cut the recurrence of melanoma in a large late-stage trial”
Open the episode · Closing Bell: Moderna Surges, Estee Lauder Soars, TJ Maxx DeclinesListen at 1:17
Moderna’s personalized cancer vaccine reduced melanoma recurrence in a late-stage trial.
“Moderna said its personalized cancer vaccine helped cut the recurrence of melanoma in a large late stage trial.”
Open the episode · Target Posts Comp Sales Beat, Lowe's Slips on Outlook, Moderna Soars on Melanoma StudyListen at 1:21
The vaccine could help prevent melanoma tumors from spreading.
“The study also met a secondary goal, basically showing the shock could help prevent tumors from spreading to new areas of the body.”
Open the episode · Target Posts Comp Sales Beat, Lowe's Slips on Outlook, Moderna Soars on Melanoma StudyListen at 1:40
Moderna and Merck achieved the first positive final-stage trial for an mRNA cancer therapy.
“it showed the first positive final stage trial for any mRNA based cancer therapy”
Open the episode · SK Hynix Rises, Moderna Gains, Estee Lauder Soars as Results Show Turnaround Gaining SteamListen at 2:16
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.